French Top Stock Picks from Analysts

Edenred

Market Cap: €6.4b

Provides digital platform for services and payments for companies, employees, and merchants worldwide.

Trigano

Market Cap: €2.0b

Designs, manufactures, markets, and sells leisure vehicles for individuals and professionals in Europe.

Soitec

Market Cap: €1.8b

Designs and manufactures semiconductor materials worldwide.

Peugeot Invest Société anonyme

Market Cap: €1.7b

Operates as an investment company.

Ipsos

Market Cap: €1.7b

Through its subsidiaries, provides survey-based research services for companies and institutions in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Forvia

Market Cap: €1.4b

Manufactures and sells automotive technology solutions in France, Germany, other European countries, the Americas, Asia, and internationally.

Ubisoft Entertainment

Market Cap: €1.3b

Ubisoft Entertainment SA produce, publishes, and distributes video games for consoles, PC, smartphones, and tablets in both physical and digital formats in Europe, North America, and internationally.

Louis Hachette Group

Market Cap: €1.3b

Engages in the publishing and travel retail and media businesses.

Voltalia

Market Cap: €962.1m

Engages in the production and sale of energy generated by the wind, solar, hydropower, biomass, and storage plants.

Atos

Market Cap: €707.6m

Provides digital transformation solutions and services in France and internationally.

Bénéteau

Market Cap: €642.7m

Designs, manufactures, and sells boats and leisure homes in France and internationally.

Equasens Société anonyme

Market Cap: €555.4m

Provides healthcare IT solutions in Europe.

Quadient

Market Cap: €538.7m

Provides intelligent communication automation, mail-related, and parcel locker solutions for customers through digital and physical channels in North America, France, Benelux, the United Kingdom, Ireland and Germany, Austria, Italy, Switzerland, and internationally.

Valneva

Market Cap: €527.2m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

ABIVAX Société Anonyme

Market Cap: €385.5m

A clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases.

Viridien Société anonyme

Market Cap: €353.8m

Provides data, products, services, and solutions in Earth science, data science, sensing, and monitoring in North America, Latin America, the Central and South Americas, Europe, Africa, the Middle East, and the Asia Pacific.

Waga Energy

Market Cap: €337.1m

Develops and produces biomethane for the renewable natural gas industry worldwide.

Inventiva

Market Cap: €302.3m

A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of MASH and other diseases in France, the United States, and Internationally.

Delta Plus Group

Market Cap: €299.3m

Engages in design, manufacture, and distribution of a range of personal protective equipment worldwide.

Guerbet

Market Cap: €239.2m

Engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions.

SMCP

Market Cap: €236.4m

Operates as a ready-to-wear and accessories retail company in France and internationally.

Groupe Pizzorno Environnement

Market Cap: €233.4m

Provides environmental services primarily in France.

Groupe Partouche

Market Cap: €173.6m

Through its subsidiaries, operates casinos, hotels, restaurants, dancehalls, and bars in France, other European countries, and internationally.

Genfit

Market Cap: €163.0m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

La Française de l'Energie

Market Cap: €153.0m

Operates as a carbon-negative energy production company in France and internationally.

Innate Pharma

Market Cap: €147.3m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

S.A. Fountaine Pajot

Market Cap: €143.7m

Designs, develops, produces, and sells cruising catamarans worldwide.

Nanobiotix

Market Cap: €135.6m

Operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

Arverne Group

Market Cap: €133.6m

Arverne Group specialized in geothermal energy.

Freelance.com

Market Cap: €127.7m

Provides intermediation between companies and intellectual service providers in France, Germany, the United Kingdom, Morocco, Luxembourg, Switzerland, and Singapore.

OSE Immunotherapeutics

Market Cap: €127.5m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Pullup Entertainment Société anonyme

Market Cap: €123.9m

Develops, publishes, and distributes games worldwide.

Carbios SAS

Market Cap: €117.7m

Engages in design and development of enzymatic processes in France.

Compagnie Lebon

Market Cap: €103.3m

Engages in the hotel, private equity, real estate, and thermal bath businesses in France.

Cellectis

Market Cap: €99.5m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.

SA Catana Group

Market Cap: €97.1m

Manufactures and catamarans and related services in France and internationally.